Egger, J., Carter, C.M., Graham, P.J., Guley, D. and Soothill, J.F. (1985) Controlled Trial of Oligoantigenic Treatment in the Hyperkinetic Syndrome. The Lancet, 325, 540-545.
http://dx.doi.org/10.1016/S0140-6736(85)91206-1

has been cited by the following article:

• TITLE: The AD/HD Syndrome as a Group of Biological Disorders

  AUTHORS: Anders Ziegler, Magne Nødland, Dag Tveiten, Karl L. Reichelt

  KEYWORDS: AD/HD, Arousal, Genetics, Peptides, Diet, PUFA (Poly Unsaturated Fatty Acids), Monamines

  JOURNAL NAME: Open Journal of Pediatrics, Vol.6 No.1, March 8, 2016

  ABSTRACT: Problem: There is a need to collect the many and varied data on AD/HD (Attention deficit hyper-activity disorder) into a meaningful overview. Method: Based on peer reviewed and published data as well as own research we try to make sense of the physiological mechanisms resulting in the relevant symptoms. Conclusion: AD/HD clearly has a genetic disposition, but as with many other genetic syndromes, the resulting proteomics must be stressed to become manifest as disease/ disorder. A common trait in the different etiologies is lower arousal.